Immunopathology of childhood celiac disease-Key role of intestinal epithelial cells

PLoS One. 2017 Sep 21;12(9):e0185025. doi: 10.1371/journal.pone.0185025. eCollection 2017.

Abstract

Background & aims: Celiac disease is a chronic inflammatory disease of the small intestine mucosa due to permanent intolerance to dietary gluten. The aim was to elucidate the role of small intestinal epithelial cells in the immunopathology of celiac disease in particular the influence of celiac disease-associated bacteria.

Methods: Duodenal biopsies were collected from children with active celiac disease, treated celiac disease, and clinical controls. Intestinal epithelial cells were purified and analyzed for gene expression changes at the mRNA and protein levels. Two in vitro models for human intestinal epithelium, small intestinal enteroids and polarized tight monolayers, were utilized to assess how interferon-γ, interleukin-17A, celiac disease-associated bacteria and gluten influence intestinal epithelial cells.

Results: More than 25 defense-related genes, including IRF1, SPINK4, ITLN1, OAS2, CIITA, HLA-DMB, HLA-DOB, PSMB9, TAP1, BTN3A1, and CX3CL1, were significantly upregulated in intestinal epithelial cells at active celiac disease. Of these genes, 70% were upregulated by interferon-γ via the IRF1 pathway. Most interestingly, IRF1 was also upregulated by celiac disease-associated bacteria. The NLRP6/8 inflammasome yielding CASP1 and biologically active interleukin-18, which induces interferon-γ in intraepithelial lymphocytes, was expressed in intestinal epithelial cells.

Conclusion: A key factor in the epithelial reaction in celiac disease appears to be over-expression of IRF1 that could be inherent and/or due to presence of undesirable microbes that act directly on IRF1. Dual activation of IRF1 and IRF1-regulated genes, both directly and via the interleukin-18 dependent inflammasome would drastically enhance the inflammatory response and lead to the pathological situation seen in active celiac disease.

MeSH terms

  • Bacteria / immunology*
  • Biomarkers / metabolism*
  • Celiac Disease / immunology*
  • Celiac Disease / microbiology
  • Celiac Disease / pathology
  • Cells, Cultured
  • Child
  • Child, Preschool
  • Female
  • Glutens / administration & dosage
  • Humans
  • Interferon Regulatory Factor-1 / metabolism*
  • Intestinal Mucosa / immunology*
  • Intestinal Mucosa / microbiology
  • Intestinal Mucosa / pathology
  • Lymphocytes / immunology*
  • Lymphocytes / microbiology
  • Lymphocytes / pathology
  • Male

Substances

  • Biomarkers
  • IRF1 protein, human
  • Interferon Regulatory Factor-1
  • Glutens

Grants and funding

Funding was provided by the Swedish Research Council-Natural Sciences and Engineering Sciences no. 2010-5669 and 2013-4522 (to M-LH and SH); The Kempe Foundations no. SMK-1134 (to M-LH); The TORNADO-Project within the 7th EU framework program theme, grant agreement no. 222720-2 (to M-LH and OH); The Fund for Biotechnology-oriented Basic Science at Umeå University (to M-LH); The Council of the County of Västerbotten (to M-LH and OS); The Swedish Society for Celiac Disease (to M-LH and OS); Donations to the Medical Faculty, Umeå University to M-LH, the Medical Faculty, Umeå University, grants including PhD-scholarships for GP and VS to M-LH. The funding agencies had no role in study design, data collection, data analysis, decision to publish, or preparation of the manuscript.